Medical Affairs and Pharma Launches: Strategies, Budgeting and Planning with Meg Heim of Heim Global Consulting
June 21, 2022
Meg discusses how COVID-19 was a transformational moment for the pharmaceutical industry, and how it has forced companies to re-examine, at multiple levels, the way they do business. Meg and Bozidar delve into innovation in the biotech industry, and how businesses will find new methods to connect and rely on solid partnerships, by developing meaningful relationships that provide mutual value and advantages. Meg also talks about how innovation has influenced the activities of Medical Affairs and MSLs, and the evolving role of Medical Affairs in pharma launches.
Pharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-Like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free Guide
In this episode, Bozidar is joined by Meg Heim, President and Founder of Heim Global Consulting.
- How can pharma develop meaningful relationships and solid partnerships?
- What is the importance of team engagement in the pharmaceutical industry in the face of shifting methods used by customers?
- How can the pharmaceutical industry adapt to new budgeting models to maximize customer interactions and investor contributions?
- What impact did pharma innovations have had on the activities of Medical Affairs and MSLs?
And connect with the host and guest here:
About The Show:
“Pharma Launch Secrets” is a podcast by Evermed and hosted by CEO Bozidar Jovicevic. We host direct, actionable conversations with world-leading pharma launch experts and help you stay up-to-date with the latest trends and strategies to help you launch your product successfully.
Check out our three most downloaded episodes:
Pharma Launch Secrets is handcrafted by our friends over at fame.so